One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2020-139847
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2020 |
 Citations: 21 |
Affiliation: Augusta University Health, Prince Aly Khan Hospital, KU Leuven, Baylor University Medical Center, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Ziekenhuisnetwerk Antwerpen Stuivenberg, Sahyadri Hospital, Sun Pharma Advanced Research (India), The University of Texas MD Anderson Cancer Center, King's College Hospital NHS Foundation Trust, Meenakshi Mission Hospital and Research Centre, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Hospital, Institute Paoli-Calmettes, University of Utah, Memorial Sloan Kettering Cancer Center, Sun Chemical (United States), Imperial College London, Hammersmith Hospital, University of Milano-Bicocca, Hôpital Lyon Sud, Catholic University of Korea, Seoul St. Mary's HospitalPhase 1 Trial of Vodobatinib, a Novel Oral BCR-ABL1 Tyrosine Kinase Inhibitor (TKI): Activity in CML Chronic Phase Patients Failing TKI Therapies Including Ponatinib
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
